Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 181 | 573.1 | 967 | 621.9 | 60 | 202.4 | 374 | 251.8 |
| Esophagus | * | # | 11 | 6.9** | * | # | 15 | 10.4** |
| Stomach | * | # | 20 | 13.9 | * | # | 10 | 6.7** |
| Colon excluding Rectum | 18 | 64.2** | 68 | 45.8 | 7 | 26.2** | 31 | 23.2 |
| Rectum and Rectosigmoid Junction | * | # | 27 | 17.5 | * | # | 4 | # |
| Liver | * | # | 9 | 5.6** | * | # | 6 | 3.5** |
| Pancreas | 5 | 17.3** | 20 | 13.1 | * | # | 17 | 10.8** |
| Lung and Bronchus | 30 | 99.0 | 171 | 108.1 | 21 | 68.8 | 139 | 89.2 |
| Melanoma of the Skin | 6 | 17.1** | 32 | 20.3 | * | # | 7 | 4.2** |
| Prostate | 57 | 177.2 | 299 | 197.1 | * | # | 27 | 22.1 |
| Urinary Bladder | 9 | 29.8** | 66 | 42.7 | * | # | 10 | 7.4** |
| Kidney and Renal Pelvis | 6 | 16.4** | 29 | 16.8 | * | # | 4 | # |
| Brain and Other Nervous System | * | # | 18 | 10.6** | * | # | 11 | 6.4** |
| Non-Hodgkin Lymphoma | * | # | 29 | 18.1 | * | # | 12 | 8.0** |
| Myeloma | * | # | 11 | 7.3** | * | # | 6 | 4.5** |
| Leukemia | * | # | 26 | 17.1 | * | # | 16 | 11.2** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 182 | 435.1 | 901 | 439.0 | 63 | 145.3 | 382 | 182.4 |
| Colon excluding Rectum | 14 | 32.0** | 72 | 33.2 | 8 | 18.1** | 36 | 17.1 |
| Rectum and Rectosigmoid Junction | 5 | 11.3** | 21 | 10.3 | * | # | 4 | # |
| Liver | * | # | 6 | 2.8** | * | # | 6 | 2.7** |
| Pancreas | 5 | 12.2** | 29 | 13.8 | * | # | 27 | 12.8 |
| Lung and Bronchus | 28 | 67.2 | 158 | 76.4 | 18 | 42.5** | 121 | 57.8 |
| Melanoma of the Skin | * | # | 23 | 12.0 | * | # | 3 | # |
| Breast | 64 | 153.4 | 269 | 132.4 | 13 | 27.7** | 52 | 24.7 |
| Cervix Uteri | * | # | 19 | 9.5** | * | # | 8 | 3.9** |
| Corpus Uteri | * | # | 38 | 18.7 | * | # | 5 | 2.5** |
| Ovary | * | # | 24 | 11.9 | * | # | 17 | 8.2** |
| Urinary Bladder | 8 | 19.1** | 25 | 12.1 | * | # | 8 | 3.9** |
| Kidney and Renal Pelvis | * | # | 24 | 11.6 | * | # | 11 | 5.1** |
| Brain and Other Nervous System | * | # | 11 | 5.6** | * | # | 2 | # |
| Non-Hodgkin Lymphoma | 11 | 26.0** | 38 | 18.0 | * | # | 16 | 7.6** |
| Myeloma | * | # | 7 | 3.4** | * | # | 4 | # |
| Leukemia | * | # | 22 | 10.6 | * | # | 13 | 5.8** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
